Interferon Shows Promise in Some Lymphatic Cancers
A National Cancer Institute study finds synthetic human interferon caused tumor shrinkage of at least half in nine of 76 patients, with five lymphatic cancer cases showing notable responses. Shrinkage lasted three to seven months, and adverse effects were similar to natural interferon, including fever and fatigue. Further research is ongoing.
MENTIONED IN THIS ARTICLE
Associated Press
Chicago
Stephen A. Sherwin
Sherwin
National Cancer Institute
Bethesda
Hodgkins
United States
Genetic flaws found in some lymphoma cells
University of Minnesota researcher Dr. Jorge Yunis reports abnormalities in chromosomes of non-Hodgkin's lymphoma cells. He studied 74 patients, finding changes in 71, suggesting chromosome analysis can guide treatment and explain disease severity. Similar defects relate to other cancers and may inform higher drug doses or bone marrow transplants.
MENTIONED IN THIS ARTICLE
Minneapolis
University of Minnesota
Jorge Yunis
Yunis
Genentech
Hoffmann-La Roche
New hope for diabetics: Humulin from recombinant DNA
Insulin-dependent diabetics move toward a lab-made human insulin called Humulin, produced via recombinant DNA by Genentech and Eli Lilly. FDA approved Oct. 29, with doctors evaluating patient suitability and continuing current regimens until broader use.
MENTIONED IN THIS ARTICLE
Patricia McCormack
Genentech Inc
San Francisco
Calif
Food and Drug Administration
United States
Irving L. Spratt
American Diabetes Association
Spratt
FDA
Robert A. Swanson
Genentech
Eli Lilly
City of Hope National Medical Center
Lilly
Also Mentioned on This Page
Thomas Merigan
Stanford University School of Medicine
Eli Lilly and Company
United Kingdom
Indianapolis
Liverpool
England
Petersen
Petersen Harned von Maur
Gazette Classified
Gazette
Target
Santa
Cedar Rapids
1St Avenue
Lindale Mall
Westdale
Westdale Mall
This is just the beginning! Our collection holds over 300 years of history, including rare newspapers, obituaries, marriage records, birth records, and so much more—most of which you won’t find anywhere else!